Mirum Pharmaceuticals (MIRM)
(Delayed Data from NSDQ)
$67.72 USD
-2.37 (-3.38%)
Updated Nov 6, 2025 04:00 PM ET
After-Market: $67.77 +0.05 (0.07%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth C Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Mirum Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MIRM 67.72 -2.37(-3.38%)
Will MIRM be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for MIRM based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for MIRM
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
MIRM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for MIRM
MIRM forms 20 Day Moving Average Resistance on November 5
Mirum Pharmaceuticals (MIRM): Cantor Fitzgerald Raises Price Target to $95 | MIRM Stock News
Stifel Nicolaus Sticks to Its Buy Rating for Mirum Pharmaceuticals (MIRM)
Mirum Pharmaceuticals (MIRM) Receives a Buy from Evercore ISI
Mirum Pharmaceuticals (MIRM) Gets a Buy from Morgan Stanley